menuBe part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Focus on Future Medicine and Genetics

Innovative Approaches to Analyzing Clinical Evidence

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Clinical guidelines are available in abundance, through peer-reviewed medical journals, library-based databases and evidence-based reports. But these guidelines may not provide recommendations that are ideal for our patients’ individual needs. What if we could merge relevant data from a range of studies, creating instant meta-analyses tailored to our patients? Host Dr. Jennifer Shu explores this concept with Dr. Todd Feinman, practicing hospitalist at Harbor-UCLA Medical Center in Torrance, Calif., and founder of Doctor Evidence, a Web-based customizable digital database of disease treatment and drug efficacy information. Could medical organizations use similar mechanisms to develop policy statements or clinical recommendations?

Recommended
Details
Presenters
Comments
  • Overview

    Clinical guidelines are available in abundance, through peer-reviewed medical journals, library-based databases and evidence-based reports. But these guidelines may not provide recommendations that are ideal for our patients’ individual needs. What if we could merge relevant data from a range of studies, creating instant meta-analyses tailored to our patients? Host Dr. Jennifer Shu explores this concept with Dr. Todd Feinman, practicing hospitalist at Harbor-UCLA Medical Center in Torrance, Calif., and founder of Doctor Evidence, a Web-based customizable digital database of disease treatment and drug efficacy information. Could medical organizations use similar mechanisms to develop policy statements or clinical recommendations?

Schedule19 Sep 2024